| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2064213A1 Heteroaryl derivatives as protein kinase inhibitors |
| 06/03/2009 | EP2064204A1 Inhibitors of 5 -lipoxygenase activating protein ( flap) |
| 06/03/2009 | EP2064193A1 Heterocyclic gpr40 modulators |
| 06/03/2009 | EP2064184A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 06/03/2009 | EP2064174A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063910A2 Method of treating endothelial dysfunction |
| 06/03/2009 | EP2063886A2 Use of n-containing spirocompounds for the enhancement of cognitive function |
| 06/03/2009 | EP2063876A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 06/03/2009 | EP2063875A2 Combination pharmaceutical compositions |
| 06/03/2009 | EP1648431B1 Novel use of a polyamine-poor composition for the production of a medical human food |
| 06/03/2009 | EP1562629B1 Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP1140079B1 Assays for ligands for nuclear receptors |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN100494185C Novel quaternary ammonium compounds |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100494180C Preparation method and uses of isoquinolinium compound and its salt |
| 06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
| 06/02/2009 | US7541445 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541343 Antiproliferative agents; administering protein; restenosis, atherosclerosis; cancer |
| 06/02/2009 | US7541341 2-(4-ethylbenzyl)-5-hydroxymethylphenyl 6-O-ethoxycarbonyl- beta -D-glucopyranoside; for treatment/prevention of hyperglycemia associated with diabetes/obesity |
| 06/02/2009 | US7541337 Methods and compositions for the treatment of peripheral artery disease |
| 06/02/2009 | US7541333 Angiogenically effective unit dose of FGF-2 and method of use |
| 06/02/2009 | US7541329 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/02/2009 | US7541157 Drug screening; amplification free; antihypertensive agent; tissue distribution of radioactivity of the molecules administered is analysed in vivo using suitable imaging devices so no killing of animal is necessary |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | CA2474003C Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 06/02/2009 | CA2452253C Novel crystal of arylethenesulfonamide derivative and preparation process thereof |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2377230C Benzimidazole compounds and medicaments comprising the same |
| 06/02/2009 | CA2362594C Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2330647C Carnitine supplemented diet to prevent or alleviate ascites in broiler type poultry |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009066468A1 Particulate medical material and use thereof |
| 05/28/2009 | WO2009066113A1 Improved anti-platelet compositions and methods |
| 05/28/2009 | WO2009066085A1 Treatment of heart failure with normal ejection fraction |
| 05/28/2009 | WO2009066010A1 Method for detecting nt-probnp or the nt-probnp/probnp ratio |
| 05/28/2009 | WO2009065472A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/28/2009 | WO2009046880A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009046877A3 Use of a histrelin and leuprolide as therapeutic agents |
| 05/28/2009 | WO2009046858A3 Therapeutic uses of kisspeptin 13 and compositions thereof |
| 05/28/2009 | WO2009046822A3 Use of the peptide ymdgtmsqv as a therapeutic agent |
| 05/28/2009 | WO2009043527A3 Therapeutic use of human growth hormone 1-43 |
| 05/28/2009 | WO2009043521A3 Use of urocortin iii and urocortin i as therapeutic agents |
| 05/28/2009 | WO2009043506A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009043456A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009040051A3 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent |
| 05/28/2009 | WO2009040023A3 Use of galnon as a therapeutic agent |
| 05/28/2009 | WO2009040005A3 Use of the peptide rfmwmr as a therapeutic agent |
| 05/28/2009 | WO2009039985A3 Therapeutic uses of urocortin ii |
| 05/28/2009 | WO2009039984A3 Therapeutic uses of urocortin ii and kisspeptin ( 27-54 ) |
| 05/28/2009 | WO2009039983A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009039978A3 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof |
| 05/28/2009 | WO2009033747A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009033660A3 Use of octreotide as a therapeutic agent |
| 05/28/2009 | WO2009026657A8 Flavonoid ppar agonists |
| 05/28/2009 | WO2009010968A3 Disease treatment via antimicrobial peptides or their inhibitors |
| 05/28/2009 | WO2008156638A3 Method of treating disorders that would benefit from increased levels of bilirubin in a subject |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137668 1-Acetoxy-1-nitrosocyclohexane; congestive heart failure; used with non-steroidal anti-inflammatory drug (NSAID); treating gastrointestinal side effects associated with NSAID |
| 05/28/2009 | US20090137642 2-Acylaminothiazole Derivatives |
| 05/28/2009 | US20090137638 Thiazolidinedione analogues |
| 05/28/2009 | US20090137632 Compositions And Methods For Treating Dyslipidemia |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137601 L-Phenylalanine Derivatives |
| 05/28/2009 | US20090137587 4-[(4-Chlorobenzyl)oxy]-1-(4-[(1E)-3-(methylamino)-1-propen-1-yl]phenyl)pyridin-2(1H)-one; remedy for metabolic disorders such as obesity, diabetes, hormone disorder; cardiovascular disorders (stenocardia, acute or congestive heart failure); nervous system disorders (bulimia, anxiety, epilepsy etc.) |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137560 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 05/28/2009 | US20090137548 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors |
| 05/28/2009 | US20090137535 Substituted oxazolidinone derivatives |
| 05/28/2009 | US20090137520 Cardiovascular disorders such as tachycardia and atrial flutter, angina, myocardial infarction, diabetes, obesity, ischemia; for example 4-[N-({9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-hydroxymethyl)tetrahydrofuran-2-yl]-6-(cyclopentylamino)purin-2-yl}methyl)carbamoyl]benzenesulfonic acid |
| 05/28/2009 | US20090137518 Therapeutic Antiangiogenic Endostatin Compositions |
| 05/28/2009 | US20090137516 Compositions and methods of treating dyslipidemia |
| 05/28/2009 | US20090137498 Substituted benzene derivatives or salts thereof |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090137040 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136560 Coated medical device |